 
        
      
    About
UI/UX
The 11th Annual KIDNEYcon
April 23-25, 2026
Little Rock, AR
 
            Little Rock, AR
 
            Kidney biopsy specimen collected in the Kidney Biopsy Workshop
KIDNEYcon 2026
KIDNEYcon aims to create an interactive learning experience where attendees can closely interact with expert presenters in a way that is not possible at larger meetings.
KIDNEYcon is a platform for nephrologists and medicine trainees to interact with each other and experts from across the nation and learn about and discuss recent advancements in the diagnosis and treatment of kidney disease. The conference will provide participants with the tools to correctly identify and determine optimal prevention and treatment of patients with acute kidney injury, glomerular disease, or complex pregnancy issues. The program will feature seven hands-on workshops that simulate realistic practice conditions utilizing case studies, simulations, and live human models to teach how and why interventions are done and allow attendees to practice new techniques.
Thursday, April 23
Symposium: Practical Aspects of Continuous Kidney Replacement Therapies
Friday, April 25
Hands-On Workshops:
- Kidney Pathology 
- Home Dialysis 
- Urine Microscopy 
- Acid/Base Fluids and Electrolytes 
- Kidney Biopsy Academy 
- Vascular Access 
- POCUS 
Keynote Address/Dinner/JEOPARDY!
Saturday, April 24
Scientific and Clinical Sessions:
- New Therapies in Glomerular Diseases 
- Rare and Genetic Kidney Diseases 
- Advances in Kidney Transplantation and Renal Replacement Therapies - Martinis, Meatballs, & Mentoring Party 
Support
We would like to thank the following companies for support of the 2024 KIDNEYcon meeting through medical education grants:
- Alexion / AstraZeneca 
- Arkana Laboratories 
- Baxter 
- Calliditas 
- Travere 
Exibitors
We would like to thank the following companies for exhibiting during the 2024 KIDNEYcon meeting:
- Alexion 
- Amgen 
- Aurinia 
- Bayer 
- Calliditas 
- CorMedix 
- CSL Vifor 
- ExThera 
- GlaxoSmithKline 
- Horizon 
- La Jolla 
- Natera 
- Novartis 
- NxStage 
- Sanofi 
- Travere 
 
            KIDNEYcon Director
John Arthur, MD, PhD, FASN
Education
University of Iowa College of Medicine
MD, 1990
PhD Pharmacology, 1990
Duke University Medical Center
Residency in Medicine, 1990-93
Fellowship in Nephrology, 1993-96
Academic Position
Professor and Chief of Nephrology
Associate Director, Translational Research Institute
University of Arkansas for Medical Sciences
Research Interests
- Prognostic Biomarkers 
- Proteomics 
- Acute Kidney Injury 
- Chronic kidney disease 
- Diabetic nephropathy 
 
            KIDNEYCON CO-DIRECTOR
Shree Sharma, MD, FASN
Education
All India Institute of Medical Sciences
MD, 2005
University of Arkansas for Medical Sciences
Residency in Pathology, 2007-2011
Columbia University Medical Center
Fellowship in Renal Pathology, 2011-2012
Academic Position
Nephropathologist, Arkana Laboratories
Little Rock, AR
Research Interests
Acute kidney injury
Chronic kidney disease
 
            KIDNEYcon Education Director
Manisha Singh, MD
Education
Rajendra Medical College (now known as RIIMS) in India MD, 2001
University of Arkansas for Medical Sciences
Residency in Medicine, 2010-2013
University of Arkansas for Medical Sciences
Fellowship in Nephrology, 2013-2015
Academic Position
Associate Professor of Nephrology Director Home Dialysis Co-Director M2 Medical Students Renal Module University of Arkansas for Medical Sciences
Research Interests
Telemedicine and CKD education Women’s health Diabetic kidney disease Medical education
 
            KIDNEYCON co-DIRECTOR
Juan Carlos Velez, MD
Education
Universidad Peruana Cayetano Heredia, San Martin de Porres, Lima, Peru
MD, 1998
Illinois Masonic Medical Center
Residency in Medicine, 2000-02
Chief Resident, 2001-02
Emory University School of Medicine
Fellowship in Nephrology, 2002-05
Academic Position
Professor and System Chair of Nephrology
Ochsner Health
Research Interests
Hepatorenal acute kidney injury Hyponatremia Glomerular diseases Renal syndromes associated with exposure to antimicrobials
 
           
                 
                 
                 
                